281 Normalization of MCP1 and sCD40L after systemic treatment with bone marrow derived mesenchymal stromal cells correlated with clinical benefits in patients with recessive dystrophic epidermolysis bullosa

M. Arriba, L. Martínez-Santamaría, R. Sacedón, R. Maseda, L. Quintana, N. Butta,S. Herraiz-Gil,R. De Lucas,M. Del Río, M. Escámez

Journal of Investigative Dermatology（2022）

引用 0|浏览4

暂无评分

关键词

recessive dystrophic epidermolysis bullosa,mesenchymal stromal cells,mcp1,bone marrow,scd40l

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要